Latest News and Press Releases

- 私人配售完成後，Enlivex 將透過累積 RAIN 代幣，採用全球首個 RAIN 預測市場代幣數碼資產儲備策略。 - RAIN 作為完全去中心化的預測與期權協定，重塑預測市場生態系統，並為鏈上市場創建提供專為透明度、自動化及社區參與而精心打造的強大平台。 - 意大利前總理 Matteo Renzi 先生將於私人配售完成後獲委任加入 Enlivex 董事局。 - Enlivex...

- 私募融资完成后，Enlivex 将通过积累 RAIN 代币，采用全球首个基于 RAIN 预测市场代币的数字资产储备战略。 - RAIN 是一个完全去中心化的预测与期权协议，重新定义了预测市场生态系统，并为链上市场的创建提供强大支撑——平台以透明度、自动化和社区参与为核心理念而构建。 - 意大利前总理 Matteo Renzi 先生将在私募融资完成后获任 Enlivex 董事会成员。 -...

- Selepas penutupan penempatan persendirian, Enlivex akan mengguna pakai strategi perbendaharaan aset digital token pasaran ramalan RAIN pertama di dunia melalui pengumpulan token RAIN. - RAIN ialah...

- Upon the closing of the private placement, Enlivex will adopt the world’s first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. - RAIN is a fully...

Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

Ness-Ziona, Israel, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that...

New York, USA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight CRISPR therapies offer...

Nes-Ziona, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, will participate in a...

Ottawa, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The global systemic inflammatory response syndrome treatment market size reached USD 13.85 billion in 2024. It is projected to rise from USD 14.89 billion...

 Allocetra™ demonstrated statistically significant and clinically meaningful improvements in pain and function in Phase IIa trial in primary osteoarthritis patients   Six-month data expected...